Catalyst Wire Dossier Catalyst Wire Dossier

PCSK9 antibody

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PCSK9 antibody, covering 2015-09-29 to 2024-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody [NA]

See pricing